Purchase Order N6817124P0088

Award Date 7/10/24
Potential Completion Date 10/31/24
Potential Value $184K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jordan
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to First National Medical Services CO. LLC, a minority-owned for-profit business. The contract, valued at $85,138.20, is for the delivery of FTD Respiratory Pathogens 33 testing kits. This contract supports BUMED's medical programs and their diagnostic capabilities for respiratory pathogens. The contract does not utilize any set-aside...
The U.S. Navy's Bureau of Medicine and Surgery (BUMED) awarded a $26,796.00 firm-fixed-price purchase order contract to First National Medical Services CO. LLC, a minority-owned business, for the provision of research and surveillance supplies. The contract has an ultimate completion date of September 30, 2024. First National Medical Services CO. LLC has a history of supplying the Navy with Fast Track Diagnostic (FTD) Respiratory Pathogens testing kits, with similar contracts awarded annually...
This is a firm-fixed-price purchase order valued at $85,138.20 awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to First National Medical Services CO. LLC, a minority-owned small business based in Amman, Jordan. The contract provides 30 multiplexed polymerase chain reaction (PCR) kits capable of testing for up to 33 respiratory pathogens, including bacteria and viruses. This requirement was awarded as a sole-source contract under the authority of FAR...
This is a $195,034.32 firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Naval Medical Research Command (NMRC) to Biofire Defense LLC, a for-profit limited liability company based in Utah. The contract is for the delivery of Biofire's medical diagnostic testing kits, including the Respiratory Panel 2.1, Warrior Panel, and Global Fever Special Pathogens Panel assays. This contract is not set aside and is being procured under the FAR Part 12 Commercial Items...
This is a firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostic products. The contract has a value of $98,828.24 and covers the delivery of a RFIT ASY 0124 RP PANEL, which appears to be some type of scientific equipment or testing product. The contract is part of the larger Scientific...
The Department of the Navy Bureau of Medicine and Surgery awarded a $175,995.80 firm fixed price purchase order to Life Technologies Corporation for the delivery of COVID-19 testing kits and related laboratory supplies. The products to be provided under the contract include TaqPath RT-PCR COVID-19 test kits, MagMAX Proteinase K enzyme preparation kits, and other molecular diagnostics reagents. Performance will take place in Silver Spring, Maryland through January 2024. As the parent company,...
This is a $83,175 firm fixed price purchase order awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC on March 31, 2020 for the delivery of COVID-19 coronavirus test kits. The contract has a performance period ending on September 30, 2020. Biofire Defense is a for-profit limited liability company that manufactures biological agent identification products, including diagnostic testing systems, and has previously held prime and subcontract awards to provide...
This is a $97,910.86 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of RFIT-ASY-0124-GSA FAIV Kits, a type of respiratory equipment, with a completion date of September 28, 2018. Biofire Defense has previously received other prime and subcontract awards from various federal agencies...
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a U.S. Navy organization, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of 100 "Global Fever Panel - RUO, 6 Tests" products, which are diagnostic assays used for infectious disease testing and biodefense applications. The contract has a ceiling value of $99,270.00 and a period of performance ending on February 1, 2019. This award was...
This is a $90,878.59 firm fixed price delivery order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for the delivery of Film Array kits, including the GI Panel, Bio Threat E, and FAIV Kits, which support respiratory infection testing. The contract has no set-aside designation and was issued under the Multiple Award Schedule (MAS) contract vehicle....

This firm-fixed-price, $184,196.40 purchase order was awarded on July 10, 2024 by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to First National Medical Services CO. LLC, a minority-owned, for-profit business. The contract is for the delivery of Fast Track Diagnostic (FTD) Respiratory Pathogens testing kits to support the Navy's medical diagnostic capabilities. This is the latest in a series of annual contracts awarded to First National Medical Services CO. LLC for these respiratory pathogen detection supplies, indicating an ongoing business relationship. The contract does not utilize any set-aside designations, reflecting the company's ability to meet direct federal procurement requirements as a minority-owned vendor.

Generated 2/20/25, 9:36 AM